479 related articles for article (PubMed ID: 33195415)
1. Systematic Analysis of Coronavirus Disease 2019 (COVID-19) Receptor ACE2 in Malignant Tumors: Pan-Cancer Analysis.
Song J; Han J; Liu F; Chen X; Qian S; Wang Y; Jia Z; Duan X; Zhang X; Zhu J
Front Mol Biosci; 2020; 7():569414. PubMed ID: 33195415
[TBL] [Abstract][Full Text] [Related]
2. System Analysis of Adaptor-Related Protein Complex 1 Subunit Mu 2 (AP1M2) on Malignant Tumors: A Pan-Cancer Analysis.
Yi Y; Zhang Q; Shen Y; Gao Y; Fan X; Chen S; Ye X; Xu J
J Oncol; 2022; 2022():7945077. PubMed ID: 35154321
[TBL] [Abstract][Full Text] [Related]
3. Integrated analysis of NET-DNA receptor CCDC25 in malignant tumors: Pan-cancer analysis.
Cheng X; Yin X; Song J
Health Sci Rep; 2023 Oct; 6(10):e1621. PubMed ID: 37841944
[TBL] [Abstract][Full Text] [Related]
4. Siglec-9, a Putative Immune Checkpoint Marker for Cancer Progression Across Multiple Cancer Types.
Wu Y; Huang W; Xie Y; Wang C; Luo N; Chen Y; Wang L; Cheng Z; Gao Z; Liu S
Front Mol Biosci; 2022; 9():743515. PubMed ID: 35372497
[TBL] [Abstract][Full Text] [Related]
5. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
6. Clinical and immunological characteristics of TGM3 in pan-cancer: A potential prognostic biomarker.
Zhang W; Wu C; Zhou K; Cao Y; Zhou W; Zhang X; Deng D
Front Genet; 2022; 13():993438. PubMed ID: 36685895
[No Abstract] [Full Text] [Related]
7. Systematic pan-cancer analysis identifies
Chen P; Yang X; Wang P; He H; Chen Y; Yu L; Fang H; Wang F; Huang Z
Ann Transl Med; 2023 Jan; 11(2):121. PubMed ID: 36819495
[TBL] [Abstract][Full Text] [Related]
8. Revealing the roles of TLR7, a nucleic acid sensor for COVID-19 in pan-cancer.
Huang Z; Gao Y; Han Y; Yang J; Yang C; Li S; Zhou D; Huang Q; Yang J
Biosaf Health; 2023 May; ():. PubMed ID: 37362864
[TBL] [Abstract][Full Text] [Related]
9. Pan-Cancer Analysis Revealed
Liu J; Wang Y; Yin J; Yang Y; Geng R; Zhong Z; Ni S; Liu W; Du M; Yu H; Bai J
J Oncol; 2022; 2022():3477148. PubMed ID: 35069733
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatic Analysis of Correlation between Immune Infiltration and COVID-19 in Cancer Patients.
Huang X; He C; Hua X; Kan A; Sun S; Wang J; Li S
Int J Biol Sci; 2020; 16(13):2464-2476. PubMed ID: 32760213
[TBL] [Abstract][Full Text] [Related]
11. Expression of the SAR2-Cov-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer.
Zhang H; Quek K; Chen R; Chen J; Chen B
J Cancer; 2020; 11(18):5289-5292. PubMed ID: 32742475
[TBL] [Abstract][Full Text] [Related]
12. The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.
Zhang Z; Li L; Li M; Wang X
Comput Struct Biotechnol J; 2020; 18():2438-2444. PubMed ID: 32905022
[TBL] [Abstract][Full Text] [Related]
13. The potential role of abnormal angiotensin-converting enzyme 2 expression correlated with immune infiltration after SARS-CoV-2 infection in the prognosis of breast cancer.
Jiang Y; Chen L; Shen J; Mei X; Yao J; Chen T; Zhou Y
Aging (Albany NY); 2021 Aug; 13(17):20886-20895. PubMed ID: 34413267
[TBL] [Abstract][Full Text] [Related]
14. Pan-Cancer Analysis of the N6-Methyladenosine Eraser FTO as a Potential Prognostic and Immunological Biomarker.
Zhao C; Liu Y; Ju S; Wang X
Int J Gen Med; 2021; 14():7411-7422. PubMed ID: 34744452
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2.
Cui Y; Chen F; Gao J; Lei M; Wang D; Jin X; Guo Y; Shan L; Chen X
Int J Biol Sci; 2021; 17(14):3795-3817. PubMed ID: 34671200
[No Abstract] [Full Text] [Related]
16. BRCA1-Associated Protein Is a Potential Prognostic Biomarker and Is Correlated With Immune Infiltration in Liver Hepatocellular Carcinoma: A Pan-Cancer Analysis.
Ju Q; Li XM; Zhang H; Zhao YJ
Front Mol Biosci; 2020; 7():573619. PubMed ID: 33240929
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets.
Zhang Y; Gao C; Cao F; Wu Y; Chen S; Han X; Mo J; Qiu Z; Fan W; Zhou P; Shen L
Front Oncol; 2021; 11():755341. PubMed ID: 34804946
[TBL] [Abstract][Full Text] [Related]
18. EF-Hand Domain-Containing Protein D2 (EFHD2) Correlates with Immune Infiltration and Predicts the Prognosis of Patients: A Pan-Cancer Analysis.
Wang Y; Song M; Gao B
Comput Math Methods Med; 2022; 2022():4878378. PubMed ID: 35341013
[TBL] [Abstract][Full Text] [Related]
19. Pan-Cancer Analysis Based on
Zhang Y; Wang S; Han S; Feng Y
Front Oncol; 2022; 12():844794. PubMed ID: 35359375
[TBL] [Abstract][Full Text] [Related]
20. Prognostic and Immunological Value of Angiotensin-Converting Enzyme 2 in Pan-Cancer.
Feng H; Wei X; Pang L; Wu Y; Hu B; Ruan Y; Liu Z; Liu J; Wang T
Front Mol Biosci; 2020; 7():189. PubMed ID: 33088807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
